Skip to content

Author

Rui-Gang Hou

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Comparison of Beiyi® and its reference product Enantone® as agonists of luteinizing hormone-releasing hormone against prostate cancer: a multicenter, randomized single-dose study

Background Leuprolide acetate is a potent agonist of luteinizing hormone-releasing hormone that has been licensed to treat prostate cancer. The microsphere formulation of leuprolide acetate called Beiyi®, developed in China, has shown favorable pharmacokinetics, pharmacodynamics and safety similar to those of the refer...

Yu-Yao Yi, P. Shen, Tong-Sen Zheng et al. · 0 citations
Open access Sep 2026

Clinical gradient and predictors for stepwise resistance escalation of carbapenem-susceptible, carbapenem-resistant, and difficult-to-treat resistant Pseudomonas aeruginosa infections: a 6-year retrospective cohort study

Objective Difficult-to-treat resistant Pseudomonas aeruginosa (DTR-PA) represents the most severe antimicrobial resistance phenotype of P. aeruginosa, with limited therapeutic options and poor clinical outcomes. However, previous studies have largely focused on carbapenem-resistant P. aeruginosa (CRPA), and the factors...

Lin Chen, Dong-Hong Yin, Hui-Min Hu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.